Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NRG Energy Inc (NRG) vs Smith & Nephew plc (SNN) Price & Performance

NRG Energy IncTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

NRG Energy Inc vs Smith & Nephew plc — how do they compare? NRG Energy Inc trades at $106.97 (market cap $22.35B), while Smith & Nephew plc trades at $27.05 (market cap $11.10B). The key difference: NRG Energy Inc is far larger — about 2× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.95%). Which is the better fit depends on your goals — on Pluang, investors hold NRG Energy Inc for 62 Days and Smith & Nephew plc for 120 Days on average.

NRGSNN
Market Cap
$22.35B$11.10B
Volume
5,011,9421,051,703
Sector
UtilitiesHealth
52-Week High
$184.03$37.17
52-Week Low
$95.23$26.42
Typical Hold Time
62 Days120 Days
Enterprise Value
$46.30B$14.13B
Dividend Yield
1.79%2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NRG Energy Inc

NRG Energy (NRG) trades at $108.61, up 4.84% today, with a bullish technical signal and strong analyst consensus. Recent earnings showed a Q2 2026 miss but the company is executing a growth strategy including a 1.2 GW Texas data-center power project. Financials indicate solid revenue of $30.71B in 2025, though net margins are thin at 2.56%, and cash flow trends are volatile with a projected net outflow in 2026.

The outlook is positive given high analyst buy ratings and a $202.90 price target, but risks include execution on large capital projects, rising debt levels, and competitive pressures. Earnings growth from new assets and customer relationships remains the key catalyst for upside, though the stock faces near-term volatility from recent misses.

Smith & Nephew plc

SNN trades at $26.89, near its 52-week low, with a bearish technical signal. Revenue and net income have grown steadily, reaching $6.16B and $625M in 2025, respectively, with improving margins. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio. However, cash flow volatility and mixed analyst sentiment pose challenges.

The stock presents a value opportunity with reasonable valuation ratios (P/E 18.34, P/S 1.85), but risks include competitive pressures and recent CFO departure. Analyst consensus is cautious, with 65% hold ratings. Upside depends on execution of growth initiatives amid market headwinds.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NRG
6% Buy94% Sell
Avg holding period · 62 Days
SNN

No sentiment data available yet.

Top news

Latest headlines on both assets

About NRG Energy Inc

NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.

Read more on NRG →

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →